Sandra A Johnson
Overview
Explore the profile of Sandra A Johnson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
365
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Legg A, Meagher N, Johnson S, Roberts M, Cass A, Scheetz M, et al.
Clin Drug Investig
. 2022 Nov;
43(1):35.
PMID: 36401785
No abstract available.
2.
Porter A, Sherry N, Andersson P, Johnson S, Duchene S, Howden B
PLoS Genet
. 2022 Oct;
18(10):e1010415.
PMID: 36227810
No abstract available.
3.
Legg A, Meagher N, Johnson S, Roberts M, Cass A, Scheetz M, et al.
Clin Drug Investig
. 2022 Oct;
43(1):23-33.
PMID: 36217068
Background: Clinical risk factors for nephrotoxicity in Staphylococcus aureus bacteraemia remain largely undetermined, despite its common occurrence and clinical significance. In an international, multicentre, prospective clinical trial (CAMERA2), which compared...
4.
Lane C, Sherry N, Porter A, Duchene S, Horan K, Andersson P, et al.
Lancet Public Health
. 2021 Jul;
6(8):e547-e556.
PMID: 34252365
Background: A cornerstone of Australia's ability to control COVID-19 has been effective border control with an extensive supervised quarantine programme. However, a rapid recrudescence of COVID-19 was observed in the...
5.
Tong S, Lye D, Yahav D, Sud A, Owen Robinson J, Nelson J, et al.
JAMA
. 2020 Feb;
323(6):527-537.
PMID: 32044943
Importance: Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia is associated with mortality of more than 20%. Combining standard therapy with a β-lactam antibiotic has been associated with reduced mortality, although adequately powered...
6.
Imam N, Spelman T, Johnson S, Worth L
Qual Manag Health Care
. 2018 Dec;
28(1):39-44.
PMID: 30586121
Background: Staphylococcus aureus bloodstream infection (SAB) in health care settings contributes significantly to mortality, and improved processes are associated with reduced burden of infection. In Australia, health care-associated SAB (HA-SAB)...
7.
Johnson S, Wang D, Bennett N, Bull A, Richards M, Worth L
Aust N Z J Public Health
. 2017 Jul;
41(5):545-546.
PMID: 28712142
No abstract available.
8.
Johnson S, Bennett N, Bull A, Richards M, Worth L
Aust N Z J Public Health
. 2016 Mar;
40(3):281-3.
PMID: 27028703
Objective: Annual influenza vaccination is recommended for all Australian healthcare workers (HCWs). In 2014, a target vaccination uptake of 75% was set for Victorian healthcare facilities. This study aimed to...
9.
Bennett N, Johnson S, Richards M, Smith M, Worth L
Infect Control Hosp Epidemiol
. 2016 Feb;
37(5):610-2.
PMID: 26842775
Our survey of 112 Australian aged-care facilities demonstrated the prevalence of healthcare-associated infections to be 2.9%. Urinary tract infections (UTIs) defined by McGeer criteria comprised 35% of all clinically defined...
10.
Aicken C, Armstrong N, Cassell J, MacDonald N, Bailey A, Johnson S, et al.
BMC Health Serv Res
. 2012 Jul;
12:202.
PMID: 22805183
Background: Decision Analytic Models (DAMs) are established means of evidence-synthesis to differentiate between health interventions. They have mainly been used to inform clinical decisions and health technology assessment at the...